Journal of Molecular Oncology Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Commentary - Journal of Molecular Oncology Research (2024) Volume 8, Issue 2

Surgical oncologists discuss the latest in tumor resection methods.

Raghab Swin *

Department of Oncology, University of Melbourne, Australia

*Corresponding Author:

Department of Oncology
University of Melbourne

Received:08-Mar-2024, Manuscript No. AAMOR-24-136487; Editor assigned:09-Mar-2024, PreQC No. AAMOR-24-136487(PQ); Reviewed:23-Mar-2024, QC No. AAMOR-24-136487; Revised:28-Mar-2024, Manuscript No. AAMOR-24-136487(R); Published:04-Apr-2024, DOI:10.35841/ 8(2):224

Citation: Swin R. Surgical oncologists discuss the latest in tumor resection methods. J Mol Oncol Res. 2024;8(2):224

Visit for more related articles at Journal of Molecular Oncology Research


The field of surgical oncology is continuously evolving, with advancements in tumor resection methods playing a crucial role in improving patient outcomes. Surgical oncologists are at the forefront of these developments, leveraging new techniques and technologies to enhance precision, reduce recovery times, and increase the effectiveness of cancer treatments. In this article, we explore the latest innovations in tumor resection methods as discussed by leading surgical oncologists. One of the most significant advancements in tumor resection is the widespread adoption of minimally invasive surgical techniques. Laparoscopic and robotic-assisted surgeries have revolutionized the approach to tumor removal, offering numerous benefits over traditional open surgery [1].

These methods involve smaller incisions, which lead to reduced pain, less blood loss, shorter hospital stays, and faster recovery times. This technique utilizes small incisions through which a laparoscope (a thin tube with a camera) and surgical instruments are inserted. The camera provides a magnified view of the surgical area, allowing surgeons to perform precise tumor resections with minimal disruption to surrounding tissues. Building on the principles of laparoscopy, robotic-assisted surgery provides even greater precision and control. Surgical oncologists operate robotic arms from a console, using high-definition 3D visualization and enhanced dexterity to perform complex resections. This method is particularly beneficial for tumors in difficult-to-reach areas and for procedures requiring meticulous dissection [2].

The integration of advanced imaging technologies into surgical procedures has markedly improved the precision of tumor resections. Image-guided surgery employs real-time imaging techniques such as MRI, CT scans, and intraoperative ultrasound to help surgeons visualize the tumor and surrounding structures during the operation. These imaging modalities provide detailed, real-time views of the surgical field, enabling surgeons to make more informed decisions during the resection process. Intraoperative MRI is particularly useful for brain and spinal surgeries, where it is critical to distinguish between tumor tissue and healthy tissue with high accuracy. Another innovative approach is fluorescence-guided surgery, where fluorescent dyes that specifically bind to cancer cells are injected into the patient. Under special lighting, these dyes cause the tumor to glow, providing a clear distinction between cancerous and healthy tissues. This technique enhances the surgeon's ability to achieve complete tumor removal while preserving normal tissue [3].

In addition to traditional surgical techniques, non-traditional methods such as laser and radiofrequency ablation are gaining traction for certain types of tumors. These techniques are minimally invasive and can be used in conjunction with or as alternatives to conventional surgery. Laser ablation involves using focused laser energy to destroy cancer cells. It is particularly effective for small, localized tumors and can be performed with minimal damage to surrounding tissues. Laser ablation is often used in liver, lung, and brain cancers. RFA uses high-frequency electrical currents to generate heat, which destroys cancer cells. A probe is inserted into the tumor under imaging guidance, delivering targeted energy to ablate the tumor. RFA is commonly used for liver, kidney, and lung tumors and offers the advantage of being performed on an outpatient basis [4].

Intraoperative radiation therapy (IORT) combines surgery with a single dose of radiation delivered directly to the tumor site during surgery. This approach allows for a high concentration of radiation to be applied precisely where it is needed, reducing the risk of damage to surrounding healthy tissues. IORT is particularly useful for cancers that are difficult to treat with conventional radiation therapy alone, such as certain abdominal and pelvic tumors. The use of 3D printing technology is emerging as a transformative tool in surgical oncology. Patient-specific 3D-printed models of tumors and surrounding anatomy enable surgeons to plan and practice complex resections before the actual procedure. Additionally, 3D printing allows for the creation of custom surgical tools and implants tailored to the patient's unique anatomy, enhancing the precision and effectiveness of tumor resections [5].


The latest advancements in tumor resection methods are redefining the field of surgical oncology. Techniques such as minimally invasive surgery, image-guided surgery, laser and radiofrequency ablation, intraoperative radiation therapy, and patient-specific 3D printing are at the forefront of this evolution. These innovations not only improve the precision and efficacy of tumor resections but also enhance patient outcomes and quality of life. As surgical oncologists continue to embrace and refine these cutting-edge techniques, the future of cancer surgery looks increasingly promising.


  1. Hall SF, Groome PA, Irish J, Radiotherapy or surgery for head and neck squamous cell cancer: establishing the baseline for hypopharyngeal carcinoma? 2009; 115(24):5711-22.
  2. Indexed atGoogle scholarCross Ref

  3. Eckel HE, Staar S, Volling P, et al. Surgical treatment for hypopharynx carcinoma: feasibility, mortality, and results. Otolaryngol Head Neck Surg 2001;124:561–9
  4. Indexed atGoogle scholarCross Ref

  5. Martin A, Jäckel MC, Christiansen H, et al. Organ preserving transoral laser microsurgery for cancer of the hypopharynx. The Laryngoscope. 2008;118(3):398-402.
  6. Indexed atGoogle scholarCross Ref

  7. Ho CM, Ng WF, Lam KH, et al. Submucosal tumor extension in hypopharyngeal cancer. Archives of Otolaryngol Head Neck Surg. 1997;123(9):959-65.
  8. Indexed atGoogle scholarCross Ref

  9. Godballe C, Jørgensen K, Hansen O, et al. Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery. The Laryngoscope. 2002;112(5):834-8.
  10. Indexed atGoogle scholarCross Ref

  11. Kurman RJ, Shih IM.Pathogenesis of ovarian cancer. Lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 2008;27(2):151.
  12. Indexed atGoogle ScholarCross Ref

  13. Carlson JW, Miron A, Jarboe EA, et al.Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol. 2008;26(25):4160.
  14. Indexed atGoogle ScholarCross Ref

  15. Levanon K, Crum C, Drapkin R. New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol.2008;26(32):5284.
  16. Indexed atGoogle ScholarCross Ref

  17. Ayhan A, Kurman RJ, Vang R, et al. Defining the cut-point between low-and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis. Am J Surg Pathol. 2009;33(8):1220.
  18. Indexed atGoogle ScholarCross Ref

  19. Norquist BM, Harrell MI, Brady MF, et al. Inherited mutations in women with ovarian carcinoma. JAMA onco. 2016;2(4):482-90.
  20. Indexed atGoogle ScholarCross Ref


Get the App